WCN

What WCN does

WCN (Werkgroep Cardiologische centra Nederland) is a Dutch non-profit cardiovascular clinical research network founded in 1987 and headquartered at Moreelsepark 1 in Utrecht, Netherlands. The organization comprises 49 cardiovascular research groups (vakgroepen) distributed across Dutch hospitals, making it the primary national platform for cardiovascular clinical research in the Netherlands. WCN operates from Holland Heart House alongside NHR, NVVC, CVOI, NLHI, DCVA, and Nefrovisie, and functions as a member-driven research association rather than a corporate entity. Its core purpose is to reduce fragmentation in multi-center cardiovascular trials by providing centralized expertise, infrastructure, and a large network of experienced investigators.

WCN's service portfolio spans four interconnected lines. The WCN Studieportfolio runs both industry-initiated cardiovascular trials (sponsored by pharmaceutical companies and CROs) and investigator-initiated studies (via the Clinical Operations WCN (COW) division, which also handles drug-repurposing and Registry Based Clinical Trials). The WCN Cursusaanbod provides continuing education for research professionals, including Basiscursus Cardiologie, Excel training, and Echo & Afwijkingen courses, held at the Utrecht office. The annual WCN Congress (next edition November 2026) features the WCN Onderzoeksprijs (Research Prize for researchers under 35), the Dunselman Named Lecture, and research presentations. All services are delivered in compliance with ICH-GCP guidelines, the Dutch WMO regulatory framework, and GDPR/AVG data protection requirements, supported by standardized SOPs and risk-based trial monitoring.

The business model is a professional services model anchored on clinical trial operations. WCN generates revenue from sponsor fees for industry-initiated trials routed through its network, service fees for investigator-initiated and ARO-sponsored work executed by the COW division, and modest training fees (€175 per course for non-members, free for members). Go-to-market is sales-led and relationship-driven: pharmaceutical companies and CROs approach WCN as a one-stop partner for Dutch cardiovascular trial execution, while academic researchers access COW for study management support. The organization is governed by its membership and through partnerships with the Dutch CardioVascular Alliance (DCVA), the Dutch Clinical Research Foundation (DCRF), and Platform OnderzoekersNetwerken (PON), which embed WCN in Dutch clinical research governance. WCN employs 27 staff and is privately held with no external parent company or recorded funding rounds.

Name

WCN

Legal name

Werkgroep Cardiologische centra Nederland (WCN)

Website

https://wcn.life

Company type

Private

Founded year

1987

Operating status

Operating

Headcount range

11–50 employees

Short description

WCN is a Dutch non-profit cardiovascular clinical research network uniting 49 research centers to run industry- and investigator-initiated trials, deliver training, and host an annual congress for pharmaceutical companies, CROs, AROs, and academic researchers.

Ownership category

akta.pro rank

Product category

Cardiovascular Clinical Research Services

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Professional, Scientific, and Technical Services (54)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)

akta.pro industry

PRIMARYHLAFAMAL

Clinical Research & Trial Central Laboratories

Healthcare & Life Sciences/Healthcare Providers & Systems/Clinical Laboratories

SECONDARYHLAGAEAA

Central Laboratory Services (Core Lab Operations)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Central Labs & Clinical Diagnostics Services (Trial Support)

SECONDARYBPAHALAH

Technical & Scientific Expert Networks

Business & Public Services/Professional Services (Legal, Accounting, Consulting)/Research, Analytics & Expert Services

Keywords

• Cardiovascular clinical research
• Clinical trial network
• Investigator-initiated studies
• Clinical operations services
• Multi-center trial management

Headquarters

HQ city

Utrecht

HQ country

Netherlands

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Infrastructure, Technology or R&D

Revenue model

1. Clinical Research Services: WCN provides comprehensive clinical research services to pharmaceutical companies, CROs, and academic researchers, including site selection, project management, monitoring, and regulatory support. Revenue appears to come from service fees for clinical trial operations, though specific pricing structures are not publicly disclosed.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

WCN operates a centralized cardiovascular clinical research network of 49 research centers across the Netherlands, providing clinical trial operations services including protocol design, regulatory support, site selection, project management, site monitoring, contract management, and educational training for research professionals. The network serves pharmaceutical companies, CROs, and academic research organizations conducting both industry-initiated and investigator-initiated cardiovascular studies.

Product overview

WCN (Werkgroep Cardiologische centra Nederland) is a cardiovascular clinical research network consisting of 49 research centers across the Netherlands. The organization functions as a unified research network rather than a traditional platform with modular components. Its core offerings consist of the WCN Study Portfolio (conducting both industry-initiated and investigator-initiated cardiovascular clinical trials), Clinical Operations WCN (COW) providing end-to-end research support services including protocol design, regulatory submission, site selection, project management, and monitoring), WCN Course Offerings (continuing education for research professionals including cardiology basics, echocardiography, and Excel training), the annual WCN Congress (featuring the Dunselman Named Lecture and Research Awards), and the WCN Research Prize recognizing young cardiovascular researchers. All services are delivered in compliance with ICH-GCP guidelines and Dutch regulatory requirements.

Differentiator

Problem solved

Functional benefit

Brands

• Clinical Operations WCN (COW): A dedicated division within WCN that handles investigator-initiated studies, academic research organizations (ARO) studies, drug-repurposing studies, and Registry Based Clinical Trials.

Products and services

• WCN Studieportfolio (Study Portfolio) A comprehensive portfolio of cardiovascular clinical research projects spanning large-scale international clinical trials, researcher-initiated academic studies, and registry-based projects. Includes both industry-initiated and investigator-initiated studies across ASCVD, heart failure, rhythm disorders, and primary prevention, delivered through the network's 49 cardiovascular research centers.
• Clinical Operations WCN (COW) A dedicated division providing end-to-end clinical operations services for investigator-initiated studies, academic research organization (ARO) studies, drug-repurposing studies, and Registry Based Clinical Trials. Services include scientific expertise from protocol design to publication, regulatory support, site selection, project management, site monitoring, contract management, and training.
• WCN Cursusaanbod (Course Offerings) A varied educational program for research teams, including beginning and experienced research professionals and research nurses. Topics range from cardiology-specific themes such as Basiscursus Cardiologie and Echo & Afwijkingen (echocardiography) to efficiency training like Excel I: Basis PLUS. Courses are delivered at the WCN office in Utrecht.

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Partnerships

Four partnerships are on record, tiered core.

• Dutch CardioVascular Alliance (DCVA)coreStrategic or Co-development PartnerDCVA brings together 23 leading organizations including patient representatives, researchers, healthcare providers, financiers, and industry to collectively address cardiovascular disease challenges. WCN is an official DCVA partner, contributing expertise in clinical research to the alliance's mission of improving cardiovascular care through innovation and research.
• Dutch Clinical Research Foundation (DCRF)coreStrategic or Co-development PartnerDCRF is a foundation facilitating clinical research to ensure valuable knowledge and science benefits patients quickly. Representatives from various stakeholders including university medical centers, STZ hospitals, CROs, pharmaceutical companies, researchers, ethics committees, patients, and government form the DCRF board.
• Platform OnderzoekersNetwerken (PON)coreStrategic or Co-development PartnerPlatform connecting research networks in the Netherlands to share expertise on regulatory implementation (Wet Mensgeboden Onderzoek) across all research phases. PON represents researchers in working groups and boards of DCRF, Programma Regeldruk, and Programma ZE&GG. Partners include Pedmed-NL, Trialbureau IKNL, WCN, ZE&GG, Ontregel het Onderzoek, Netherlands Heart Institute, and V&VN BOOG.
• Holland Heart HousecoreOthersWCN is located in Holland Heart House, the national platform for cardiovascular care, science, and education. This shared facility also houses NHR (Netherlands Heart Registry), NVVC (Dutch Society for Cardiology), CVOI (Netherlands Institute for Permanent Cardiovascular Education), NLHI (Netherlands Heart Institute), DCVA, and Nefrovisie.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• ICON plc: Top-three global CRO providing cardiovascular clinical trial services. ICON serves as a broader incumbent competitor to WCN for industry-initiated cardiovascular trials, offering global reach and full-service capabilities versus WCN's Netherlands-focused network.
• Duke Clinical Research Institute (DCRI): Leading academic cardiovascular clinical research organization globally. DCRI runs large multi-center cardiovascular trials with deep pharma relationships and research operations expertise, operating as a larger-scale U.S. parallel to WCN's model.
• IQVIA: Largest global CRO with extensive cardiovascular clinical research capabilities and established presence in the Netherlands. IQVIA represents the global incumbent alternative that pharma sponsors may select instead of WCN's regional network.
• Parexel International: Major global CRO with cardiovascular trial experience. Parexel competes directly with WCN for industry-sponsored Dutch cardiovascular studies by offering multinational execution that WCN's Netherlands-only model cannot match.
• TIMI Study Group: Cardiovascular-focused academic research organization at Brigham and Women's Hospital/Harvard. TIMI conducts landmark cardiovascular trials and operates as a comparable specialty ARO with established sponsor relationships, though U.S.-based and at greater scale.

Direct peers

• Netherlands Heart Institute (NLHI): Dutch cardiovascular research organization co-located with WCN in Holland Heart House. NLHI focuses on preclinical and translational cardiovascular research, while WCN concentrates on clinical trial execution, making them complementary peers in the Dutch cardiovascular research ecosystem.
• Pedmed-NL: Dutch pediatric medicines research network operating on the same multi-center, sponsor-coordinating model as WCN but focused on pediatrics. Both are core PON platform partners and use comparable governance, SOP-driven operations, and academic engagement structures.
• IKNL / Trialbureau IKNL: Dutch oncology-focused clinical trial bureau with similar structure to WCN's COW division. IKNL coordinates multi-site oncology trials across Dutch hospitals under a network model and is also a PON platform partner, making it structurally comparable to WCN.
• ZE&GG (Platform on Regulatory Burden Reduction): Dutch platform organization sharing PON membership with WCN. ZE&GG addresses clinical trial regulatory burden reduction, overlapping with WCN's regulatory submission support and SOP standardization services for multi-center trials.

Emerging players

• Baim Institute for Clinical Research: Cardiovascular-focused clinical research organization founded by renowned interventional cardiology researchers. Baim provides cardiovascular clinical operations and research services, operating as a U.S.-based specialty peer with comparable cardiovascular research focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/vereniging-wcn

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about WCN